Toggle light / dark theme

New research has found that artificial intelligence (AI) analyzing medical scans can identify the race of patients with an astonishing degree of accuracy, while their human counterparts cannot. With the Food and Drug Administration (FDA) approving more algorithms for medical use, the researchers are concerned that AI could end up perpetuating racial biases. They are especially concerned that they could not figure out precisely how the machine-learning models were able to identify race, even from heavily corrupted and low-resolution images.

In the study, published on pre-print service Arxiv, an international team of doctors investigated how deep learning models can detect race from medical images. Using private and public chest scans and self-reported data on race and ethnicity, they first assessed how accurate the algorithms were, before investigating the mechanism.

“We hypothesized that if the model was able to identify a patient’s race, this would suggest the models had implicitly learned to recognize racial information despite not being directly trained for that task,” the team wrote in their research.

New information from a study reported in Stem Cells might result in more effective treatments for osteoarthritis and other cartilage diseases, as well as hereditary disorders affecting cartilage development. Their findings might also point to a new way to accelerate stem cell differentiation for bioengineering cartilage, the researchers say.

The scientists behind the new device were working within the realm of nano-supercapacitors (nBSC), which are conventional capacitors but scaled down to the sub-millimeter scale. Developing these types of devices is tricky enough, but the researchers sought to make one that could work safely in the human body to power tiny sensors and implants, which requires swapping out problematic materials and corrosive electrolytes for ones that are biocompatible.

These devices are known as biosupercapacitors and the smallest ones developed to date is larger than 3 mm3, but the scientists have made a huge leap forward in terms of how tiny biosupercapacitors can be. The construction starts with a stack of polymeric layers that are sandwiched together with a light-sensitive photo-resist material that acts as the current collector, a separator membrane, and electrodes made from an electrically conductive biocompatible polymer called PEDOT: PSS.

Novel Cultivated Meats For Earth (And Space!) — Dr. Neta Lavon Ph.D., CTO / VP of R&D, Aleph Farms.


Dr. Neta Lavon is the Chief Technology Officer (CTO) and Vice President of R&D at Aleph Farms (https://www.aleph-farms.com/), a cultivated meat company that is shaping the future of food by growing high-quality, slaughter-free beef steaks directly from cow cells, preserving natural resources, and avoiding the use of antibiotics.

Dr. Lavon is an expert in stem cell applications in biotechnology. In her previous position as the COO of Kadimastem (KDST), she developed cell therapy products from stem cells for ALS and Diabetes.

As a researcher in Cedars-Sinai in Los Angeles, USA, Dr. Lavon established and banked 25 novel pluripotent stem cell lines.

Dr. Lavon holds a PhD, an M.Sc. in Biotechnology and B.Sc. in Food Sciences from the Hebrew University, Israel.

The ‘Joker’ virus hides in several apps on the Google Play Store and the user does not realize it until their bank accounts are emptied. See how this malware operates and what are the dangerous applications.


In September 2,020 the ’Joker’ virus was found in 24 Android applications that registered more than 500 thousand downloads before being removed. It is estimated that that time it affected more than 30 countries including the United States, Brazil and Spain. Through unauthorized subscriptions, hackers could steal up to $7 (about 140 Mexican pesos) per subscription weekly, a figure that has most likely increased in recent months.

How does the Joker virus work in Android apps?

The ’Joker’ Trojan virus belongs to a family of malware known as Bread 0 whose objective is to hack cell phone bills and authorize operations without the user’s consent.

Lipids are abundant in the brain, where they are found not just in the cell membranes of neurons, whose properties they modulate, but also in the so-called myelin sheaths insulating axons — the brain’s ‘wiring.’ The brain is therefore a surprisingly ‘fat’ organ — in fact, it is nearly 60% fat, the study’s first author, Anna Tkachev from Skoltech, said.


Summary: Prozac reduced polyunsaturated fatty acid lipid concentrations in the brains of juvenile macaque monkeys.

Source: Skoltech

Skoltech researchers and their colleagues from Russia, Germany, and the U.S. have found Prozac to reduce lipid concentrations in juvenile macaques who received the antidepressant for two years, compared to a control group of untreated animals.

While none of the monkeys in the study were depressed, the findings still offer a plausible biochemical explanation for the drug’s side effects, particularly in young patients. The paper was published in the International Journal of Molecular Sciences.

A team at Penn’s medical school discovered that an epigenetic regulatory protein called ZMYND8 governs the expression of genes that are critical for the growth and survival of AML cells. Inhibiting ZMYND8 in mouse models shrank tumors. The researchers also found a biomarker that they believe could predict which patients are likely to respond to ZMYND8 inhibition, they reported in the journal Molecular Cell.

AML is one of the hardest leukemias to treat, with a five-year survival rate of about 27% in adults. The Penn team had been searching for precision medicine approaches that could improve the prognosis for adults with AML, and they turned to CRISPR for help.

ZMYND8 is known as a “histone reader” in cancer that can recognize epigenetic changes and influence gene expression involved in metastasis.

What we’ll soon see is the ultimate self-directed evolution fueled forward by gene editing, genetic engineering, reproduction assisted technology, neuro-engineering, mind uploading and creation of artificial life. Our success as a technological species essentially created what might be called our species-specific “success formula.” We devised tools and instruments, created new methodologies and processes, and readjusted ecological niches to suit our needs. And our technology shaped us back by shaping our minds. In a very real sense, we have co-evolved with our technology. As an animal species among many other species competing for survival, this was our unique passage to success.

#TECHNOCULTURE : #TheRiseofMan #CyberneticTheoryofMind


Technology has always been a “double-edged sword” since fire, which has kept us warm and cooked our food but also burned down our huts. Today, we surely enjoy the fruits of modern civilization when we fly halfway around the globe on an airbus, when we extend our mental functionality with a whole array of Internet-enabled devices, when our cities and dwellings become icons of technological sophistication.

Innovation in the amino-sciences for health, wellness, and aging — dr. tia rains phd, VP customer engagement & strategic development, ajinomoto.


Dr. Tia Rains, Ph.D., is Vice President of Customer Engagement & Strategic Development at Ajinomoto Health & Nutrition North America, Inc. (https://www.ajihealthandnutrition.com/), a division of Japanese food and biotechnology Ajinomoto Corporation (https://www.ajinomoto.com/), which produces seasonings, cooking oils, frozen foods, beverage, sweeteners, amino acids, and pharmaceuticals.

Dr. Rains has over 20 years of experience working on health and wellness initiatives within the food and beverage sector, and enjoys working at the intersection of nutrition research and communications, with the goal of advancing credible research in nutrition and developing truthful messaging on new research results in the context of the body of nutrition evidence.

Dr. Rains most recently headed up the Egg Nutrition Center (ENC) as it’s Executive Director.

Prior to joining ENC, Dr. Rains was the Senior Director of Metabolic Sciences at Biofortis Clinical Research, a global contract research organization specializing in the design and conduct of clinical research for leading food, beverage, and supplement companies around the world.